Anaemia treatment reduces costs in NDD patients with renal failure Clinical study 20 April 2019 Pages: 4 - 4
Budget impact overestimated in Dutch reimbursement dossiers Clinical study 20 April 2019 Pages: 5 - 5
Continuous subcutaneous insulin infusion not cost effective Clinical study 20 April 2019 Pages: 6 - 6
Economic burden of CF substantial in Germany, and likely to rise Clinical study 20 April 2019 Pages: 12 - 12
Fluticasone furoate/vilanterol reduces exacerbation risk in COPD Clinical study 20 April 2019 Pages: 14 - 14
High-quality modelling studies needed on back pain, sciatica Clinical study 20 April 2019 Pages: 16 - 16
Lopinavir/ritonavir cost effective for HIV with viral suppression Clinical study 20 April 2019 Pages: 17 - 17
Mismatch between R&D budget and burden of disease in Korea Clinical study 20 April 2019 Pages: 18 - 18
Phenotyping cost effective in reducing risk of myelosuppression Clinical study 20 April 2019 Pages: 20 - 20
Potential value of genomic testing in early breast cancer Clinical study 20 April 2019 Pages: 21 - 21
PrEP with 6-monthly testing cost effective for MSM and PWID Clinical study 20 April 2019 Pages: 22 - 22
Preventive drugs overprescribed at end of life of elderly with cancer Clinical study 20 April 2019 Pages: 24 - 24
Prohylactic antibiotics beneficial during chemoradiotherapy for HNC Clinical study 20 April 2019 Pages: 25 - 25
Reimbursement decisions on drugs for renal cell carcinoma Clinical study 20 April 2019 Pages: 27 - 27
Rivaroxaban better value in morbidly obese patients with AF Clinical study 20 April 2019 Pages: 28 - 28
Systemic sclerosis with interstitial lung disease: substantial burden Clinical study 20 April 2019 Pages: 30 - 30
Vaccines play significant role in controlling HCV among PWID Clinical study 20 April 2019 Pages: 33 - 33
Variation in medical costs among people living with HIV/AIDS in US Clinical study 20 April 2019 Pages: 34 - 34